Page 28 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH

IMR ANNUAL REPORT 2021 15

CaRC Research

Principal
No. Research Title NMRR Number investigator /
Co-principal
investigator
Clinically Actionable Genes for the CENTRE (CaRC) CANCER RESEARCH
1 Management of Nasopharyngeal NMRR-18-264-40228 Dr Tan Lu Ping
Carcinoma
Investigating Nasopharyngeal
2 Carcinoma (NPC) - Derived Epstein- NMRR-18-623-41161 Norazlin Abd
Barr Virus (EBV) Variants from Malaysia Aziz

Development of Model Systems to
3 NMRR-18-596-41153 Marini Marzuki
Study Nasopharyngeal Carcinoma
Identification of New Primate Dr Tan Lu Ping /
Adenovirus Subtypes for Development
4 NMRR-19-2705-50872 Dr Florence Lee
into Replication-Deficient Adeno-
Vector Backbones Chi Hiong
Long Non-Coding RNAs (IncRNAs) Dr Norafiza
5 NMRR-19-2280-48428
Profiling in Beta-Thalassemia Patients Mohd Yasin
Genetic Variation Associated with
Bortezomib Induced Peripheral Dr Sujatha A/P
6 NMRR-19-2274-48525
Neuropathy in Adult Multiple Myeloma Suthandiram
Patients
Multi-centre Clinico-Pathological Dr Hans
7 Study of Malaysian Patients with Oral NMRR-20-1351-55551 Prakash A/L
Squamous Cell Carcinoma Sathasivam

Transcriptomic Profiling for Genetic
Characterisation of Multiple Myeloma Nor Soleha
8 NMRR-20-2408-56967
Patients with Drug Resistance: A Pilot Mohd Dali
Study
Pre-Clinical Evaluation of Human
9 Mesenchymal Stem Cell (hMSC) NMRR-20-3011-57629 Dr Lim Moon
Nian
Derived Exosome Eye Drops
Study on Southeast Asian Ovalocytosis
with Thalassaemia Interaction Among Dr Norafiza
10 Sixteen-Year Old Students Participating NMRR-20-29-52612 Mohd Yasin
in National Thalassaemia Screening
Programme in Kuala Lumpur

Profiling of BCR-ABL1 Kinase
Domain Mutation in Chronic Myeloid
11 Leukaemia Patients with Imatinib NMRR-19-3693-52311 Dr Yuslina Mat
Resistance Using Next Generation Yusoff
Sequencing